Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/eAwUCduTtWCjjtuECidyqVCicNdNQw
| Today's Top Story |  |  | | - Report: Global biotech firms raised $11B in first half of 2013
The global biotechnology sector secured nearly $11 billion in funding during the first half of 2013, 37.6% higher compared with the same period last year, according to BioWorld Snapshots. Public offerings accounted for around 63% of the total. Global biotech firms raised nearly $6 billion in the second quarter, 20% more than in the first quarter. BioWorld (free content) (7/3)       | Health Care & Policy | | | | - Study predicts strong global growth for drug industry
With the peak of generic competition for patented drugs in the past, the pharmaceutical industry is poised for sustained growth that will reach a total value of $895 billion in the next five years, according to the annual World Preview by the research firm Evaluate. The report predicts that, by 2018, biological products will constitute half of the sales of the top 100 products worldwide, Novartis will be the world's largest pharmaceutical firm, AbbVie's tumor necrosis inhibitor Humira will be the biggest-selling drug product, and anticoagulant therapies will become the fastest-growing sector, increasing more than 11% in five years. PharmaTimes (U.K.) (7/2) - Gene therapy for stem cells may improve sickle cell disease treatment
Researchers at the University of California at Los Angeles are working on a gene therapy for bone marrow stem cells that could allow patients with sickle cell disease, who do not have a bone marrow match, to receive transplants using their own modified bone marrow. The treatment involves the addition of an anti-sickling gene in patients' hematopoietic stem cells. Researchers hope to initiate human trials in 2014. Their work is outlined in an online report in the Journal of Clinical Investigation. Los Angeles Wave (7/2) | Company & Financial News | | | | | Food & Agriculture | | | | - Survey: Most U.K. farmers want to grow biotech crops
Sixty-one percent of U.K. farmers would plant biotech crops if it's legal to do so and 47% think biotech crops should be used to maximize production and profitability, according to a survey of 625 independent farmers. A separate survey, however, found that a minority of U.K. consumers were open to supporting biotech foods. FoodBev.com/Barclays (7/3) | Industrial & Environmental | | | | - 4 biomass-to-fuel ventures secure federal grants
Four biomass-to-fuel projects received a total of $13 million in federal funding aimed at promoting advanced biofuels. The recipients are Ceramatec in Salt Lake City, Oak Ridge National Laboratory in Tennessee, the University of Oklahoma, and Virent in Madison, Wis. DomesticFuel.com (7/2)  | |  | | The Buzz(CORPORATE ANNOUNCEMENTS)
| |  | |  |
| News from BIO | | | | - Secure document sharing services optimized for life science organizations
ShareVault, a leading provider of highly secure and controlled document sharing solutions and virtual data rooms (VDR), has aligned with BIO to provide companies with significant discounted pricing and complimentary extra features. ShareVault's VDR platform is optimized for life science companies of all sizes and flexibly priced so that even small biotech companies can afford and benefit from its technology. The ShareVault solution is intended for due diligence required during bio-pharma partnering, licensing, fundraising, M&A, clinical study management or other applications that require secure sharing of documents with third parties. Learn more and sign up for a free trial.
| SmartQuote | | | |  | Beware of false knowledge; it is more dangerous than ignorance."
--George Bernard Shaw,
Irish playwright and essayist  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Wednesday, July 03, 2013
- Tuesday, July 02, 2013
- Monday, July 01, 2013
- Friday, June 28, 2013
- Thursday, June 27, 2013
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | | | | | | © 1999-2013 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment